Luna’s Voice-enabled PT Charting System, Auto-Charting®, Helps Physical Therapists Save Time and Reduce Burnout

Luna, the leading provider of in-home physical therapy, has found that Auto-Charting®, the only voice-enabled physical therapy charting system available in the market, is helping thousands of physical therapists save significant time and reduce the risk of burnout.

Luna calculated that in 2022, the amount of time Auto-Charting® saved its physical therapists is the equivalent of flying to Mars and back at least two times. With the current shortage in the healthcare workforce across the industry, clinician productivity has never been more paramount.

In a traditional clinic, physical therapists spend 8-10 minutes filling out each chart at the end of a patient session. Auto-Charting® drastically reduces this time, as physical therapists quickly answer targeted questions live over their phone, which takes about three minutes. Luna automatically generates a high-quality patient chart for approval and once signed, Luna instantly pays the therapist for their completed case.

Video clip: Auto-Charting® in action.

“Voice-enabled technologies like Alexa and Siri make life easier. Auto-Charting is no different,” said Ryan Gaffney, Luna CTO and co-founder, and former Uber senior software engineer who co-developed Auto-Charting®. “While the healthcare sector is experiencing widespread labor shortages, Auto-Charting helps physical therapists save a lot of time. Our technology platform enables us to attract more physical therapists than any other provider, especially with the current staffing crisis, and that’s why Luna is the fastest-growing physical therapy clinic in the US.”

While other healthcare providers are experiencing widespread labor shortages, the number of therapists joining Luna’s platform has grown to two per hour. Luna recently hired FOX Rehabilitation’s Amber Mauro as the company’s Head of Therapist Acquisition to oversee Luna’s growth in physical therapists to 5,000+ in 2023.

 

Luna currently operates across 50 markets in 27 states and has treated 30,000+ patients in their homes. In 2022, Luna became the fastest growing physical therapy clinic nationally with 6,183 percent growth in visits during the four consecutive years since it was founded in 2018. This is higher than any reported growth during the same time frame from any physical therapy clinic group.

 

Shifting care to the home is radically transforming healthcare. According to a recent McKinsey report, up to $265 billion worth of care services (representing up to 25 percent of the total cost of care) for Medicare fee-for-service and Medicare Advantage beneficiaries are expected to shift from traditional facilities to the home by 2025.

 

 

SourceLuna

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”